Department of Defense
INSTRUCTION
NUMBER 6000.08
January 22, 2014
Incorporating Change 1, November 30, 2017
USD(P&R)
SUBJECT: Defense Health Program Research and Clinical Investigation Programs
References: See Enclosure 1
1. PURPOSE. This instruction:
a. Reissues DoD Instruction (DoDI) 6000.08 (Reference (a)) in accordance with the
authority in DoD Directive (DoDD) 5124.02 (Reference (b)) and DoDD 5136.01 (Reference (c)).
b. Establishes DoD policy, assigns responsibilities, and provides procedures for funding and
administration of Research and Clinical Investigation Programs (CIP) funded by the Defense
Health Program (DHP) appropriation.
2. APPLICABILITY. This instruction:
a. Applies to OSD, the Military Departments, the Office of the Chairman of the Joint Chiefs
of Staff and the Joint Staff, the Combatant Commands, the Office of the Inspector General of the
Department of Defense, the Defense Agencies, the DoD Field Activities, and all other
organizational entities within the DoD (referred to collectively in this instruction as the “DoD
Components”).
b. Encompasses all elements of research and CIP relating to the medical mission of the
Military Health System (MHS) funded through DHP. CIP is funded by DHP operation and
maintenance (O&M) funds and DHP research is comprised of research, development, test, and
evaluation (RDT&E) funds.
3. POLICY. It is DoD policy that:
a. DHP-funded medical research and CIP are essential missions of the MHS, intended to
achieve these objectives:
